Skip to main content
SpringerLink
Log in
Book cover

Neuro-Psychopharmaka Ein Therapie-Handbuch pp 567–579Cite as

Meclofenoxat

Centrophenoxin

  • Chapter

  • 95 Accesses

Zusammenfassung

Wirksame Bestandteile: p-Chlorphenoxyessigsäure -ß-dimethylaminoethylester. 2-Di methylaminoethyl-(4-chlorphenoxy)-acetat (IUPAC)

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ankerhold W (1975) Therapeutische Cerutil-Effekte bei intellektuell minderbefähigten, vorwiegend hirngeschädigten Kindern und bei Erwachsenen mit senilen Rückbildungsvorgängen und hirninvolutiven zerebralen Leistungsschwächen. Medicamentum (Berlin) 16: 136–137

    Google Scholar 

  • Bartus RT, Dean RL, Beer B (1983) An evaluation of drugs for improving memory in aged monkeys: implications for clinical trials in humans. Psychopharmacol Bull 19: 168–184

    PubMed  CAS  Google Scholar 

  • Becker A, Grecksch G (1994) Nootropic dugs and their effect on amygdala-kindling related learning deficits in rats. Neuropsychopharmacology 10, 3 [Suppl Pt 2]: 183S

    Google Scholar 

  • Benuzzi P, Müller C (1967) Trois methodes de traitement du delirium tremens — etude comparative. Schweiz Med Wochenschr 97: 1283–1289

    PubMed  CAS  Google Scholar 

  • Bertoni-Freddari C, Giuli C, Pieri C (1982) The effect of acute and chronic centrophenoxine treatment on the synaptic plasticity of old rats. Arch Gerontol Geriatr 1: 365–373

    Article  PubMed  CAS  Google Scholar 

  • Bielenberg GW, Hayn C, Kriglstein J (1986) Effects of cerebro-protective agents on enzyme activities of rat primary glial cultures and rat cerebral cortex. Biochem Pharmacol 35: 2693–2702

    Article  PubMed  CAS  Google Scholar 

  • Blaschke M, Fischer HD, Schmidt J (1988) Zur peroxidativen Schädigung der synaptosomalen hochaffinen Ca++-ATPase und ihrer pharmakologischen Beeinflußbarkeit. Biomed Biochim Acta 47: 887–893

    PubMed  CAS  Google Scholar 

  • Bonnes B, Kuchenbuch S (1978) Untersuchungen mit Cerutil im Doppelblindversuch bei Patienten mit überforderungssyndrom und eventuellen leichten Involutionserscheinungen. Medicamentum (Berlin) 19: 262–264

    Google Scholar 

  • Bower HM, Mcdonald C (1966) Controlled trial of A.N.P.235 („Lucidril“) in senile dementia. Med J Austr 2: 270–273

    CAS  Google Scholar 

  • Brenner H (1962) über den Wert des Dimethylaminoäthanol parachlorphenoxyazetats (Lucidril) — bei der Behandlung von Verletzungen und Erkrankungen des Gehirns. Wien Med Wochenschr 112: 347–350

    PubMed  CAS  Google Scholar 

  • Coirault R (1965) Traitment du delirium tremens. Vie Méd 46: 1749–1757

    Google Scholar 

  • Colpin F (1970) Results of treatment with centrophenoxine in a population of mentally maladjusted children (Frz.). Rev Neuropsychiatr Infant 18: 713–725

    PubMed  CAS  Google Scholar 

  • Capoun V, Kafka J (1972) Centrophenoxine and chlomethiazol in the treatment of delirium tremens. Activ Nerv Sup (Praha) 14: 118–119

    CAS  Google Scholar 

  • Cooperation Study Group on Anti-Stroke Agents; Ohtomo E, Okada T, Kameyama M, Kutsuzawa H, Itoh E, Ichimaru S, Itoh H (1975) Clinical efficacy of so-called brain metabolism activating agents in treatment of cerebrovascular disorders — a double-blind controlled study on the clinical efficacy of meclofenoxate and pyrithioxine in cerebrovascular disorders. Clin Evaluation 3: 19–45

    Google Scholar 

  • Dechaume JP (1974) Intérêt de lucidril a doses élevées dans le traitement des comas post-traumatiques. Ann Anaesth Franc 15: 549–552

    Google Scholar 

  • Dereymaker A, Theeuwissen-Lesuisse F, Buu-Hio NP, Lapiere C (I962) L’anoxie cérébrale expérimentale; effet protecteur des dérivés de l’acide p-chlorophénoxyacétique. Medicina Experimentalis 7: 239–244

    Google Scholar 

  • Dowson JH (1989) Neuronal lipopigment: a marker for cognitive impairment and long-term effects of psychotropic drugs. Br J Psychiatry 155: 1–11

    Article  PubMed  CAS  Google Scholar 

  • Fischer K, Albrecht F, Echterhoff M (1977) Behandlung bewußtseinsgestörter Patienten auf einer chirurgischen Wachstation. In: Kugler J (Hrsg) Hirnstoffwechsel und Hirndurchblutung. Schnetztor, Konstanz

    Google Scholar 

  • Fülöp T Jr, Worum I, Csongor J, Leövey A, Szabo T, Pek G, Zs-Nagy (1990) Effects of centrophenoxine on body composition and some biochemical parameters of demented elderly people as revealed in a double-blind clinical trial. Arch Gerontol Geriatr 10: 239–251

    Article  PubMed  Google Scholar 

  • Gedye JL, Exton-Smith AN, Wedgwood J (1972) A method for measuring mental performance in the elderly and its use in a pilot clinical trial of meclofenoxate in organic dementia. Age Ageing 1: 74–80

    Article  PubMed  CAS  Google Scholar 

  • Genkova-Papasova M, Lazarova-Bakurova M (1988) Influence of nootropic drugs on the memory-impairing effect of diethyldithiocar-bamate and Clonidine in „step down“ passive avoidance in albino rats. Acta Physiol Pharmacol Bulg 14: 36–41

    PubMed  CAS  Google Scholar 

  • Gheorghita N (1977) Immediate effects of neurodynamic substances on verbal performance in the treatment of aphasia. Rev Roum Méd-Neurol Psychiatr (Bucur) 15: 95–101

    CAS  Google Scholar 

  • Glees P (1982) Electron microscopic studies on neural lipofuscin: accumulation and removal. The effects of centrophenoxine in the central nervous system ceroid-lipofuscinosis (Batten’s disease). In: Armstrong D, Koppang N, Rider JA (eds) Elsevier Biomedical Press, chapter 31, pp 385–398

    Google Scholar 

  • Grau M, Balasch J (1984) Protective effects of cerebroactive drugs in a model of acute hypoxia. Gen Pharmacol 16: 37–41

    Google Scholar 

  • Greindl MG, Preat S (1976) A new model of active avoidance conditioning adequat for pharmacological studies. Arch Int Pharmacol 223: 168–170

    CAS  Google Scholar 

  • Guensberger E, Schmidt P (1966) Bedingt-reflektorische Studie in der Untersuchung von Psychoenergizern. Wien Z Nervenheilk 24: 146–150

    PubMed  CAS  Google Scholar 

  • Harris SJ, Dowson JH (1986) The effects of meclofenoxate on cognitive performance in elderly individuals with memory impairment: a placebo-controlled study. Int J Geriatr Psychiatry 1: 93–98

    Article  Google Scholar 

  • Herrmann H-D, Dittmann J (1971) Steigerung des Glukose-Stoffwechsels von Kaninchen-Hirnschnitten durch Centrophenoxin. Arzneimittelforschung /Drug Res 21: 984–985

    CAS  Google Scholar 

  • Herrschaft H, Gleim F, Duus P (1974) Die Wirkung von Centrophenoxin auf die regionale Gehirndurchblutung bei Patienten mit zerebrovaskulärer Insuffizienz. Dtsch Med Wochenschr 99: 1707–1714

    Article  PubMed  CAS  Google Scholar 

  • Hoffmann W, Rostock A (1984) Der Einfluß von Nootropica auf das postkonvulsive Verhalten. Pharmazie 39: 579–580

    PubMed  CAS  Google Scholar 

  • Hoyer S (1979) Effects of centrophenoxine on cerebral circulation in geriatric patients. In: Nandy K (ed) Geriatrie psychopharmacology. Elsevier North-Holland, pp 261–274

    Google Scholar 

  • Ichimaru S, Kudo Y, Itoh M, Vejima T et al. (1973) Double-blind controlled trial of meclofenoxate (lucidril tablet) on cerebral arteriosclerosis. Igaku no Ayumi 114: 456–464

    Google Scholar 

  • Itoh H, Kudo Y, Kabeshima Y, Nobushima S, Komine K, Sato Y (1986) Double-blind controlled trial of lucidril (meclofenoxate) in the posttraumatic syndrome, especially dizziness. Folia Psychiatr Neurol 22: 23–42

    Google Scholar 

  • Jähkel M, Oehler J, Schumacher H-E (1992) The influence of psychotropic drugs on activity of mice in the running-wheel and open-field. Pharmacopsychiatry 25: 106

    Google Scholar 

  • Jähkel M, Oehler J, Schumacher H-E (1994) Influence of nootropic and antidepressive drugs on open field and running wheel behavior in spontaneously high and low active mice. Pharmacol Biochem Behav 49: 263–269

    Article  PubMed  Google Scholar 

  • Jakob I, Burdick B (1963) Etude clinique du comportement des enfants retardes au cours du traitement par ANP 235 (parachlorophénoxy-acétate de diméthylaminoéthyle). Annales Médico-Psychologiques 1: 193–204

    Google Scholar 

  • Jänicke B, Wrobel D (1984) Changes in motor activity with age and the effects of pharmacologic treatment. Exp Gerontol 19: 321–328

    Article  PubMed  Google Scholar 

  • Kanig K, Tencheva ZS, Nitschki J, Dingler WD (1977) Der Einfluß von Centrophenoxin auf den 32P-Einbau in Nucleinsäuren und Adenosinphosphate des Rattengehirns. In: Kugler J (Hrsg) Hirnstoffwechsel und Hirndurchblutung. Schnetztor, Konstanz, S 108–112

    Google Scholar 

  • Kayaba M et al. (1975) Clinical effect of lucidril on sequela of cerebrovascular attack (Japanisch). J New Remedies Clin 24: 1407–1414

    Google Scholar 

  • Kinoshita T, Suitsu N, Yamamoto Y et al. (1985) Meclofenoxate as a nootropic agent. A quantitative pharmaco-EEG-study. Jpn J Neuropsychopharmacol 7: 741–748

    CAS  Google Scholar 

  • Kirsch U, Schmidt J (1983) Der Einfluß von Nootropika auf transkallosal ausgelöste Potentiale. Zbl Pharm Pharmakother Laboratoriumsdiagn 122: 192–195

    Google Scholar 

  • Koga T (1976) Increase of brain serotonin and its metabolite in rats caused by meclofenoxate. Folia Pharmacol Jpn 72: 392–402

    Article  CAS  Google Scholar 

  • Kohlmann T, Rett A (1963) über den Einfluß sogenannter Psychoenergizer auf die klinische und psychische Situation gehirngeschädigter Kinder. Wien Med Wochenschr 113: 356–362

    PubMed  CAS  Google Scholar 

  • Koynov R, Markov G, Minchev D (1977) Centrophenoxine — clinical test on patients with apoplexy and cerebro-cranial injury. Med Biol Information 5: 7–10

    Google Scholar 

  • Krapivin SV (1987) Neurophysiological analysis of action of nootropic drugs. Neuroscience (Oxford) 22 [Suppl]: 822

    Google Scholar 

  • Laine J, Christiaens E (1974) Meclofenoxate et traumatismes craniens graves. Ann Anesth Franc 15: 132–136

    Google Scholar 

  • Lazarova MB, Petkov VD, Mosharrof A, Markovska VL, Petkov W (1987) Effects of nootropic drugs in the electroconvulsive shock-impaired retention in „step down“ passive avoidance. Neuroscience (Oxford) 22 [Suppl]: 519

    Google Scholar 

  • Ludwig-Festl M, Gräter B, Bayreuther K (1983) Erhöhung von Zellstoffwechselleistungen in normalen, diploiden, menschlichen Glia-Zel-len in stationären Zellkulturen induziert durch Meclofenoxat. Arzneimittelforschung / Drug Res 33: 495–501

    CAS  Google Scholar 

  • Marcer D, Hopkins SM (1977) The differential effects of meclofenoxate on memory loss in the elderly. Age Ageing 6: 123–131

    Article  PubMed  CAS  Google Scholar 

  • Marc-Vergnes JP, Bes A, Celcis P, Charlet JP (1974) Action biologique et clinique du meclofenoxate a haute dose au cours des accidents vasculaires cérébraux avec troubles de la conscience (résultats préliminaires). Ann Anesth Franç 15(6)

    Google Scholar 

  • Matsunaga H, Matsuda H, Shibuya T (1986) The effects of cerebral metabolic activators on the spinal reflex and coordinated motor activities of the cerebrovascular disordered rats. Jpn J Pharmacol 40 [Suppl]: 217

    Google Scholar 

  • Mitta Y, Kishi M, Minaki Y (1967) Synthesis of 14C-labeled centrophenoxine and its distribution in the mouse. Radio Isotopes 16: 29–36

    CAS  Google Scholar 

  • Miyazaki H, Kagemoto A, Ishi M, Minaki Y, Nakamura K (1971) Uptake by brain and distribution of radioactivity after intravenous administration of 14C-labelled meclofenoxate in mice. Chem Pharm Bull 19: 1681–1690

    Article  PubMed  CAS  Google Scholar 

  • Miyazaki H, Nambu K, Minaki Y, Hashimoto M, Nakamura K (1976) Comparative studies on the metabolism of ß-dimethylaminoethanol in the mouse brain and liver following administration of ß-dimethylaminoethanol and its p-chlorophenoxyacetate, meclofenoxate. Chem Pharm Bull 24: 763–769

    Article  PubMed  CAS  Google Scholar 

  • Morton O, Goldberg A (1984) A multi-centre trial of meclofenoxate in the treatment of chronic brain syndrome. Publikationsmanuskript. Promonta GmbH, Hamburg

    Google Scholar 

  • Naab M (I967) Klinische Beobachtungen bei Anwendung von Centrophenoxin (Helfergin) bei der Alkoholpsychose und ihren metalkoholischen Erkrankungen. Med Welt 18: 1280–1282

    Google Scholar 

  • Nagy K, Zzs-nagy vs-Nagy V, Bertoni-Freddari C, Zzs-nagy is-Nagy I (1983) Alterations of the synaptosomal membrane ‘microviscosity’ in the brain cortex of rats during aging and centrophenoxine treatment. Arch Gerontol Geriatr 12: 23–29

    Article  Google Scholar 

  • Nagy-Zs I, Floyd RA (1984) Electron spin resonance spectroscopic demonstration of the hydroxil free radical scavenger properties of dimenthylaminoethanol in spin trapping experiments conforming the molecular basis for the biological effects of centrophenoxine. Arch Gerontol Geriatr 3: 297–310

    Article  Google Scholar 

  • Nagy-Zs I, Semsei I (1984) Centrophenoxine increase the rates of total and mRNA synthesis in the brain cortex of old rats: an explantation of its action in terms of the membrane hypothesis of aging. Exp Gerontol 19: 171–178

    Article  Google Scholar 

  • Nakajima H, Thuillier J (1964) L’etude electroencephalograhique et elektrocardiographique chez le lapin éveille, de l’anoxie histotoxique provoquée par le cyanure de potassium. Effects thérapeutiques de la centrophenoxin. Soc Biol (Paris) 158: 501–504

    Google Scholar 

  • Nakamura N, Makino H, Hirai H (1979) Clinical efficacy of meclofenoxate hydrochloride injection on disturbance of consciousness in head injury patients. Promonta GmbH, Hamburg (unveröffentlichtes Manuskript)

    Google Scholar 

  • Nandy K (1979) Experimental studies on centrophenoxine in aging brain. Geriatr Psychopharmacol 8: 247–260

    Google Scholar 

  • Nandy K, Bourne GH (1966) Effect of centrophenoxine on the lipofuscin pigments in the neurones of senile guinea pigs. Nature 210: 313–314

    Article  PubMed  CAS  Google Scholar 

  • Neumann H-J (1985) Einfluß von Meclofenoxat auf die Gewichtsentwicklung, Fertilität und Wurfgröße bei Wistar-Ratten. Biomed Bio-chem Acta 44: 289–300

    CAS  Google Scholar 

  • Neumann H-J, Hollnack W, Hollnack B, Froemmel H (1985) Zirkadianrhythmische Untersuchungen zur praenatal-toxischen Wirkung von Cyclophosphamid und Centrophenoxin bei Wistar-Ratten. Amt Anz 160: 345–352

    CAS  Google Scholar 

  • Nickel J, Breyer U, Claver B, Quadbeck G (1963) Zur Wirkung von Aminoethanol-Derivaten auf das Zentralnervensystem. Arzneimittelforschung /Drug Res 13: 881–883

    CAS  Google Scholar 

  • Oeriu S, Winter D, Dobre V, Bruhis S (1973) Le passage de glucose a travers la barriere hémato-encéphalique (B.H.E.) en rapport avec le vieillissement et sous l’incfluence du meclofenoxate. J Pharmacol (Paris) 4: 497–503

    CAS  Google Scholar 

  • Olivier JE, Restell M (1967) Serial testing in assessing the effect of meclophenoxate on patients with memory defects. Br J Psychiatry 113: 219–222

    Article  Google Scholar 

  • Olpe HR, Steinmann MW, Jones RSG (1985) Locus coeruleus as a target for psychogeriatric agents. Ann NY Acad Sci 444: 394–405

    Article  PubMed  CAS  Google Scholar 

  • Ostrovskaya RU, Gudashcheva TA (1991) Rapid inhibition of exploratory movements as a test of nootropic activity. Biull Eksp Biol Med 111: 498–500

    Article  Google Scholar 

  • Patro IK, Sharma SP (1984) Cytochemical interaction of nucleolus and cytoplasm in the purkinje cells of senile white rats under the influence of centrophenoxine. Exp Gerontol 19: 241–251

    Article  PubMed  CAS  Google Scholar 

  • Pék G, Fülöp T, Zzs-nagy is-Nagy I (1989) Gerontopsychological studies using NAI (Nürnberger-Alters-Inventar) on patients with organic psychosyndrome (DSM III, category 1) treated with centrophenoxine in a double blind, comparative randomized clinical trial. Arch Gerontol Geriatr 9: 17–30

    Article  PubMed  Google Scholar 

  • Perret E, Wehrli A, Hafen G (1977) Centrophenoxin bei Kindern mit Legasthenie und Lernschwierigkeiten: Objektivierung der Wirkung von Centrophenoxin anhand einer neuropsy-chologischen Testbatterie (vorläufige Resultate). In: Kugler J (Hrsg) Hirnstoffwechsel und Hirndurchblutung. Schnetztor, Konstanz

    Google Scholar 

  • Petkov VD, Mosharrof AH (1989) Memory effects of the new derivative of the p-chlorphenoxyacetic acid adafenoxate compared to the effects of some cognition-enhancing drugs in rats. Arzneimittelforschung/Drug Res 39: 1133–1136

    CAS  Google Scholar 

  • Petkov V, Zafirov D, Panova Y, Yanev S, Stancheva S (1978) On the participation of the cyclic 3′, 5′-AMP system and the brain biogenic monoamines in the mechanism of the centrophenoxine action. In: Petkov V (ed) On the pharmacology of centrophenoxine. Publishing House of the Bulgarian Academy of Sciences, Sofia

    Google Scholar 

  • Petkov W, Grahovska T, Petkov VD, Konstantinova E (1985) Effects of meclofenoxate on the level and turnover of biogenic monoamines in the rat brain. Arzneimittelforschung/Drug Res 35: 1778–1781

    CAS  Google Scholar 

  • Petkov VD, Belcheva S, Stoyanova V, Petkov VV (1990) Effects of nootropic agents on the performing of active two-way avoidance tasks in young and old rats. Acta Physiol Pharmacol Bulg 16: 35–42

    PubMed  CAS  Google Scholar 

  • Petkov VD, Konstantinova ER, Petkov W, Vaglenova JV (1991) Learning and memory in rats exposed pre-and postnatally to alcohol. An attempt at pharmacological control. Meth Find Exp Clin Pharmacol 13: 43–50

    CAS  Google Scholar 

  • Pieschl D, Angersbach P, Kolbe M, Toman M (1983) Doppelblinde Verbundstudie Centrophenoxin versus Plazebo bei Patienten mit neurasthenischen Syndromen. Nervenarzt 54: 48–53

    PubMed  CAS  Google Scholar 

  • Rinckenbach R, Massari R (1961) Essai de traitement du delirium tremens par la centrophenoxine. L’Quest Medical 14: 1029–1031

    Google Scholar 

  • Rousseva S, Petkov VV, Petkov VD, Voronina TA, Nerobkova LN, Ivanova IA, Stoyanova V (1988) Memory effects of the combination of medazepam with nootropic agents. Acta Physiol Pharmacol Bulg 14: 27–34

    PubMed  CAS  Google Scholar 

  • Roy DR, Singh R (1988) Age-related change in the multiple unit activity of the rat brain parietal cortex and the effect of centrophenoxine. Exp Gerontol 23: 161–174

    Article  PubMed  CAS  Google Scholar 

  • Roy D, Pathak DN, Singh R (1983) Effect of centrophenoxine on the antioxidative enzymes in various regions of the aging rat brain. Exp Gerontol 18: 185–197

    Article  PubMed  CAS  Google Scholar 

  • Schilter R (1974) Zur Wirkung von Cerutil (Centrophenoxin) bei zerebralsklerotischen Patienten. Z Altersforsch 28: 231–238

    CAS  Google Scholar 

  • Schmidt J (1984) Nootropic drugs reduce immobility in behavioural despair test in mice. Biomed Biochem Acta 43: 1295–1299

    CAS  Google Scholar 

  • Schmitz KW, Kühnl S (1978) Erfahrungen mit Cerutil bei organisch hirngeschädigten Kindern und Jugendlichen. Dtsch Gesundheitswesen 33: 1507–1509

    Google Scholar 

  • Sharma D, Singh R (1995) Centrophenoxine activates acetylcholinesterase activity in hippocampus of aged rats. Ind J Exp Biol 33: 365–368

    CAS  Google Scholar 

  • Sinclair KGA, Mann DMA (1980) The effects of meclophenoxate on young healthy volunteers. J Clin Exp Gerontol 2: 173–184

    CAS  Google Scholar 

  • Sliwa L, Plonka I, Dubis K, Kowalsczyk K, Srebro Z (1983) Effect of centrophenoxin on spermatogenesis in mice. Folia Biol (Krakow) 31: 101–106

    CAS  Google Scholar 

  • Stancheva SL, Alova LG (1994) Biogenic monoamine uptake by rat brain synaptosomes during aging. Effects of nootropic drugs. Gen Pharmacol 25: 981–987

    Article  PubMed  CAS  Google Scholar 

  • Stancheva S, Papazova M, Alova L, Lazarova-Bakarova M (1993) Impairment of learning and memory in shuttle box-trained rats neonatally injected with 6-hydroxydopamine. Effects of nootropic drugs. Acta Physiol Pharmacol Bulg 19: 77–82

    PubMed  CAS  Google Scholar 

  • Teichmann H, Schwebke R (1973) Die Leistungen hirnorganisch leistungsgeminderter normalintelligenter Kinder unter Cerutil im Arbeitsversuch. Psychiat Neurol Med Psychol (Leipzig) 25: 168–177

    CAS  Google Scholar 

  • Tikal K, Benesova O (1975) Active avoidance and discrimination learning in rats with protein or calorie deficit and centrophenoxine or palmitoyl ethanolamide treatment in early postnatal life. Activ Nerv Sup (Praha) 16: 159–160

    Google Scholar 

  • Vehreschild T, Beier R, Friemert K (1975) Langzeitbehandlung der Hirnleistungsschwäche in der Involution mit Cerutil — ein Doppel-blindversuch. Dtsch Gesundheitswesen 30: 280–282

    Google Scholar 

  • Vial H, Guillemin G, Pacheco H (1976) Effets de dérivés de 1 amphétamine et de produits psychotropes sur les taux de tryptophane, serotonine et d’acide hydroxy-5-indolyl-3-acétique dans le cerveau du rat. J Pharmacol (Paris) 7: 177–190

    CAS  Google Scholar 

  • Viticchi C, Gentile S, Piantanelli L (1984) Centro-phenoxine-induced increase of beta-adrenoceptor density in brain cortex of old mice. Arch Gerontol Geriatr 3: 77–82

    Article  PubMed  CAS  Google Scholar 

  • Voronina TA, Garibova TL, Trofimov SS, Sopyev ZHA, Petkov VD, Lazarova MB (1991) Comparative studies on the influence of ONK (N(5-hydroxynicotinoil) glutamic acid), piracetam and meclofenoxate on the learning-and memory-impairing effect of scopolamine, clonidine, and methergoline. Acta Physiol Pharmacol Bulg 17: 8–15

    PubMed  CAS  Google Scholar 

  • Wenzel E (1963) Vorläufige Ergebnisse der Behandlung von chronischen Hirntraumatikern mit Helfergin. Med Klin 58: 1271–1275

    PubMed  CAS  Google Scholar 

  • Wenzel J, Pögelt B (1983) Zur Wirkung ausgewählter Nootropika auf die EEG-Grundaktivität. Zbl Pharm Pharmakother Laboratoriumsdiagn 122: 188

    Google Scholar 

  • Wetzel W (1990) Effect of repeated application of nootropic drugs on sleep in rats. Biomed Biochim Acta 49: 405–411

    PubMed  CAS  Google Scholar 

  • Wetzel W, Wagner T, Matthies H (1991) Effects of nootropics and other psychotropic drugs on sleep parameters in rats. Arch Pharmacol 343[Suppl R111]

    Google Scholar 

  • Wood WG, Gorka C, Armbrecht HJ, Williamson LS, Strong R (1986) Fluidizing effects of centrophenoxine in vitro on brain and liver membranes from different age groups of mice. Life Sci 39: 2089–2095

    Article  PubMed  CAS  Google Scholar 

  • Wüthrich A, Hafen G, Vetsch M, Wehrli A, Perret E (1984) Psychologische Testleistung von Kindern mit Schulschwierigkeiten vor und nach der Behandlung mit Meclofenoxat. Med Welt 35: 558–560

    Google Scholar 

  • Yoshioka S, Aso Y, Uchiyama M (1987) Kinetics of hydrolysis of meclofenoxate hydrochloride in human plasma. J Pharm Pharmacol 39: 215–218

    Article  PubMed  CAS  Google Scholar 

  • Zdichynec B (1975) Klinische Erfahrungen bei der peroralen Therapie von manifesten Formen zerebraler Atherosklerose. Ars Medici 65: 475–478

    Google Scholar 

Download references

Authors
  1. H. Herrschaft
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinische Neurochemie, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Würzburg, Bundesrepublik Deutschland

    Peter Riederer

  2. Bezirkskrankenhaus Gabersee, Wasserburg/Inn, Bundesrepublik Deutschland

    Gerd Laux

  3. Wien, Österreich

    Walter Pöldinger

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Wien

About this chapter

Cite this chapter

Herrschaft, H. (1999). Meclofenoxat. In: Riederer, P., Laux, G., Pöldinger, W. (eds) Neuro-Psychopharmaka Ein Therapie-Handbuch. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6400-6_55

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6400-6_55

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-7315-2

  • Online ISBN: 978-3-7091-6400-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation